filmov
tv
John Teerlink, MD: GALACTIC-HF Patient Population
Показать описание
John Teerlink, MD, professor of Medicine at UCSF and Executive Committee Chair of GALACTIC-HF, discusses the most recently released data related to GALACTIC-HF.
HCPLive
omecamtiv mecarbil
cardiology
galactic-hf
heart failure
Рекомендации по теме
0:07:17
John Teerlink, MD: GALACTIC-HF Patient Population
0:05:39
GALACTIC-HF Results
0:08:49
The Relax-AHF-2 Trial: Dr John Teerlink (HFA Congress 2017 - Paris)
0:09:15
COSMIC-HF: Omecamtiv Mecarbil in Chronic Heart Failure
0:03:56
John Teerlink, MD: Impact of COVID-19 on Clinical Trials
0:02:56
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups | Dr David Lanfear
0:04:36
#HFSA2019 TV: Interview with John Teerlink, MD
0:04:29
AHA 2015 | COSMIC-HF
0:04:05
GALACTIC HF Trial: Omecamtiv mecarbil
0:06:59
ESC TV 2013 - Hotline IV: AQUARIUS and ATOMIC AHF
0:03:13
Congresso AHA.20 - Estudo GALACTIC-HF
0:05:57
GALACTIC-HF Commentary: Biykem Bozkurt, MD, PhD, FAHA
0:03:37
GALACTIC
0:29:48
Professor John McMurray - Heart failure therapy – extending the limits!
0:02:32
ESC TV at ESC Congress 2019 - GALACTIC (Investigator)
0:05:42
Omecamtiv Shows Just Modest HFrEF Benefit - Medpage Today
1:08:59
ACC Cardiology Hour From ACC.21 With Dr. Valentin Fuster
0:07:54
ACC 21: The CONNECT-HF Trial
1:08:11
Webinar 'Landmark trials in heart failure'
0:04:36
ESC 2020: Improving Heart Failure Outcomes — Prof Andrew Coats
0:11:44
#ISHLT5Qs: Five Questions With Jean-Luc Vachiery, MD
0:50:31
Webinar | JACC: Heart Failure December Virtual Journal Club - Discussion on the STAND-UP AHF Study
0:55:54
Episode 6: Implications of the Advisory Committee Meetings for the Heart Failure Community
0:32:59
New Therapies in Heart Failure with Reduced Ejection Fraction: for whom? when? ESC Asia 5th Dec 2020